Evidence map›Paper›PMID 25849486›Full record

ArticlePLoS computational biology2015

Interplay between constraints, objectives, and optimality for genome-scale stoichiometric models.

Timo R Maarleveld, Meike T Wortel, Brett G Olivier, Bas Teusink, Frank J Bruggeman

Abstract read
In one paragraph

Article in PLoS computational biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Timo R MaarleveldSystems Bioinformatics, Amsterdam Institute for Molecules, Medicines and Systems, VU University, Amsterdam, The Netherlands; Life Sciences, Centrum Wiskunde & Informatica (CWI), Amsterdam, The Netherlands.
Meike T WortelSystems Bioinformatics, Amsterdam Institute for Molecules, Medicines and Systems, VU University, Amsterdam, The Netherlands; Kluyver Centre for Genomics of Industrial Fermentation, Delft, The Netherlands.
Brett G OlivierSystems Bioinformatics, Amsterdam Institute for Molecules, Medicines and Systems, VU University, Amsterdam, The Netherlands.
Bas TeusinkSystems Bioinformatics, Amsterdam Institute for Molecules, Medicines and Systems, VU University, Amsterdam, The Netherlands; Kluyver Centre for Genomics of Industrial Fermentation, Delft, The Netherlands.
Frank J BruggemanSystems Bioinformatics, Amsterdam Institute for Molecules, Medicines and Systems, VU University, Amsterdam, The Netherlands; Kluyver Centre for Genomics of Industrial Fermentation, Delft, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-throughput data generation and genome-scale stoichiometric models have greatly facilitated the comprehensive study of metabolic networks. The computation of all feasible metabolic routes with these models, given stoichiometric, thermodynamic, and steady-state constraints, provides important insights into the metabolic capacities of a cell. How the feasible metabolic routes emerge from the interplay between flux constraints, optimality objectives, and the entire metabolic network of a cell is, however, only partially understood. We show how optimal metabolic routes, resulting from flux balance analysis computations, arise out of elementary flux modes, constraints, and optimization objectives. We illustrate our findings with a genome-scale stoichiometric model of Escherichia coli metabolism. In the case of one flux constraint, all feasible optimal flux routes can be derived from elementary flux modes alone. We found up to 120 million of such optimal elementary flux modes. We introduce a new computational method to compute the corner points of the optimal solution space fast and efficiently. Optimal flux routes no longer depend exclusively on elementary flux modes when we impose additional constraints; new optimal metabolic routes arise out of combinations of elementary flux modes. The solution space of feasible metabolic routes shrinks enormously when additional objectives---e.g. those related to pathway expression costs or pathway length---are introduced. In many cases, only a single metabolic route remains that is both feasible and optimal. This paper contributes to reaching a complete topological understanding of the metabolic capacity of organisms in terms of metabolic flux routes, one that is most natural to biochemists and biotechnologists studying and engineering metabolism.

Indexed as

Models, GeneticEscherichia coliGenome, BacterialGenomicsGlucoseSystems BiologyGlucose

Identifiers

PMID25849486
PMCPMC4388735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.